Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

ClinicalTrials.gov ID: NCT01800968

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01800968. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 5:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Functional Impact of GLP-1 for Heart Failure Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure Syndrome (AHFS) discharge period will be associated with greater clinical stability at six months as assessed by a composite clinical endpoint.

Study identification

NCT ID
NCT01800968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duke University
Other
Enrollment
300 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2013 (Type not available)
Primary completion
Oct 2015 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
Feb 15, 2017

2013 – 2015

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Christiana Care Health Services Newark Delaware 19718 —
Emory University School of Medicine Atlanta Georgia 30322 —
Northwestern University Chicago Illinois 60611 —
Johns Hopkins Hospital Baltimore Maryland 21287 —
Tufts Medical Center Boston Massachusetts 02111 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston VA Healtcare System West Roxbury Massachusetts 02132 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University St Louis Missouri 63110 —
Saint Louis University Hospital St Louis Missouri 63117 —
Duke University Durham North Carolina 27705 —
Southeast Regional Medical Center Lumberton North Carolina 28538 —
University Hospitals- Case Medical Center Cleveland Ohio 44106 —
Metro Health System Cleveland Ohio 44109 —
Cleveland Clinic Cleveland Ohio 44195 —
Lancaster Heart and Stroke Foundation Lancaster Pennsylvania 17603 —
University of Pennsylvaina Philadelphia Pennsylvania 19104 —
Jefferson Medical College Philadelphia Pennsylvania 19107 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Michael Debakey VA Medical Center Houston Texas 77030 —
Intermountain Medical Center Murray Utah 84157 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
Utah VA Medical Center Salt Lake City Utah 84132 —
The University of Vermont- Fletcher Allen Health Care Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01800968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2017 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.